Novel |
C7 |
complement C7 |
- Terminal pathway of complement
- Regulation of Complement cascade
|
|
- Late complement pathway defects, including the following seven diseases: C5 deficiency; C6 deficiency; C7 deficiency; C8 alpha-chain deficiency; C8 beta-chain deficiency; C8 gamma-chain deficiency; C9 deficiency
|
Novel |
CNOT6L |
CCR4-NOT transcription complex subunit 6 like |
- Deadenylation of mRNA
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
|
|
|
Novel |
PITX3 |
paired like homeodomain 3 |
|
|
|
Novel |
RPL19 |
ribosomal protein L19 |
- L13a-mediated translational silencing of Ceruloplasmin expression
- Peptide chain elongation
- SRP-dependent cotranslational protein targeting to membrane
- SRP-dependent cotranslational protein targeting to membrane
- Viral mRNA Translation
- Selenocysteine synthesis
- Major pathway of rRNA processing in the nucleolus and cytosol
- Formation of a pool of free 40S subunits
- GTP hydrolysis and joining of the 60S ribosomal subunit
- Eukaryotic Translation Termination
- Regulation of expression of SLITs and ROBOs
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
|
- (S)-3-phenyllactic acid
- Anisomycin
- Puromycin
|
|
Novel |
XPO7 |
exportin 7 |
|
|
|
|
- |
uncharacterized LOC401442 |
|
|
|
|
ACACA |
acetyl-CoA carboxylase alpha |
- ChREBP activates metabolic gene expression
- Biotin transport and metabolism
- Carnitine metabolism
- Activation of gene expression by SREBF (SREBP)
- Defective HLCS causes multiple carboxylase deficiency
- Fatty acyl-CoA biosynthesis
|
|
|
|
ACOT7 |
acyl-CoA thioesterase 7 |
- Mitochondrial Fatty Acid Beta-Oxidation
|
|
|
|
ADAM15 |
ADAM metallopeptidase domain 15 |
- Degradation of the extracellular matrix
- Invadopodia formation
|
|
|
|
ADCY6 |
adenylate cyclase 6 |
- Glucagon signaling in metabolic regulation
- PKA activation
- PKA activation in glucagon signalling
- Adenylate cyclase activating pathway
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- FCGR3A-mediated IL10 synthesis
|
|
|
|
ADD3 |
adducin 3 |
- Miscellaneous transport and binding events
|
|
|
|
AHDC1 |
AT-hook DNA binding motif containing 1 |
|
|
|
|
AKT1 |
AKT serine/threonine kinase 1 |
- Activation of BAD and translocation to mitochondria
- PIP3 activates AKT signaling
- PIP3 activates AKT signaling
- Downregulation of ERBB2:ERBB3 signaling
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- MTOR signalling
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the cytosol
- AKT phosphorylates targets in the nucleus
- Negative regulation of the PI3K/AKT network
- eNOS activation
- AKT-mediated inactivation of FOXO1A
- Integrin signaling
- Deactivation of the beta-catenin transactivating complex
- CD28 dependent PI3K/Akt signaling
- CTLA4 inhibitory signaling
- G beta:gamma signalling through PI3Kgamma
- Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
- KSRP (KHSRP) binds and destabilizes mRNA
- VEGFR2 mediated vascular permeability
- TP53 Regulates Metabolic Genes
- Constitutive Signaling by AKT1 E17K in Cancer
- Interleukin-4 and Interleukin-13 signaling
- Regulation of TP53 Degradation
- Regulation of TP53 Activity through Acetylation
- Regulation of TP53 Activity through Association with Co-factors
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Cyclin E associated events during G1/S transition
- Cyclin A:Cdk2-associated events at S phase entry
- PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
- RAB GEFs exchange GTP for GDP on RABs
- RUNX2 regulates genes involved in cell migration
- Regulation of PTEN stability and activity
- Extra-nuclear estrogen signaling
- Negative regulation of NOTCH4 signaling
- FLT3 Signaling
- Regulation of localization of FOXO transcription factors
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
|
- ATP
- Arsenic trioxide
- Genistein
- Inositol 1,3,4,5-Tetrakisphosphate
- Resveratrol
- Archexin
- Enzastaurin
- Perifosine
- N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
|
- PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Proteus syndrome; Proteus-like syndrome
|
|
ANKHD1 |
ankyrin repeat and KH domain containing 1 |
|
|
|
|
ANP32A |
acidic nuclear phosphoprotein 32 family member A |
- HuR (ELAVL1) binds and stabilizes mRNA
|
|
|
|
APBB1 |
amyloid beta precursor protein binding family B member 1 |
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
|
|
|
|
ARHGAP32 |
Rho GTPase activating protein 32 |
|
|
|
|
ARID5A |
AT-rich interaction domain 5A |
|
|
|
|
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
- ATF4 activates genes in response to endoplasmic reticulum stress
- Aspartate and asparagine metabolism
- Response of EIF2AK4 (GCN2) to amino acid deficiency
- Response of EIF2AK1 (HRI) to heme deficiency
|
- Aspartic acid
- Glutamic acid
- ATP
- Asparagine
|
|
|
ATF5 |
activating transcription factor 5 |
- Response of EIF2AK1 (HRI) to heme deficiency
|
|
|